Maxine Gowen
CIK 1280044 · President & CEO · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TRVN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 300
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 33,334 | $3.58 | $119.2K | $0 | 10 | 2026-06-08 |
| PASG | Director | — | $3.31 | — | $0 | 8 | 2026-05-21 |
| Merus N.V. (MRUS) Delisted | Director | — | $90.00 | — | $0 | 7 | 2025-12-12 |
| Aceragen, Inc. (ACGN) Delisted | Director | 0 | $0.38 | $0 | -$26 | 1 | 2023-08-11 |
| Aceragen, Inc. (IDRA) Delisted | Director | 129 | $7.22 | $932 | $10.5K | 11 | 2022-06-27 |
| AKBA | Director | 24,133 | $0.66 | $15.8K | -$39.7K | 8 | 2020-06-09 |
| TREVENA INC (TRVN) Delisted | President & CEO | 432 | $0.01 | $5 | $291.5K | 17 | 2020-05-15 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Director | 13,177 | — | — | -$216.3K | 16 | 2012-08-01 |
Recent Filings · Page 6 of 8
79 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-10-05 | Aceragen, Inc. (IDRA) Delisted | Buy (P) | +4,102 | $10.5K | EDGAR |
| 2016-07-06 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +6,441 | $10.5K | EDGAR |
| 2016-06-20 | AKBA | Grant (A) | — | $0 | EDGAR |
| 2016-06-15 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-31 | TREVENA INC (TRVN) Delisted | Buy (P) | +22,084 | $157.3K | EDGAR |
| 2016-03-07 | TREVENA INC (TRVN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-06 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-12 | AKBA | Grant (A) | — | $0 | EDGAR |
| 2015-03-19 | TREVENA INC (TRVN) Delisted | Mixed | −51,000 | $0 | EDGAR |
| 2014-12-10 | TREVENA INC (TRVN) Delisted | Buy (P) | +8,000 | $32.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.